| Product NDC: | 55045-1594 | 
| Proprietary Name: | Chlorzoxazone | 
| Non Proprietary Name: | Chlorzoxazone | 
| Active Ingredient(s): | 500 mg/1 & nbsp; Chlorzoxazone | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55045-1594 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA089895 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20110116 | 
| Package NDC: | 55045-1594-8 | 
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (55045-1594-8) | 
| NDC Code | 55045-1594-8 | 
| Proprietary Name | Chlorzoxazone | 
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (55045-1594-8) | 
| Product NDC | 55045-1594 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Chlorzoxazone | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20110116 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | CHLORZOXAZONE | 
| Strength Number | 500 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |